Delcath preps move, lays off staffers; Bind reports early signs of solid tumor efficacy; Bird flu toll rises;

 @FierceBiotech: Trending: Groton throws up a new hurdle to Pfizer's R&D demolition plan. Story | Follow @FierceBiotech

 @JohnCFierce: Fun list from Evaluate on the top 10 blockbuster busts in biopharma. List | Follow @JohnCFierce.

 @RyanMFierce: Started my day 2 here at BioIT13 with a story about Novartis' big decision on whether to buy Proteon in $550M deal. News | Follow 

> In a new effort aimed at improving its efficiency, Delcath is moving its headquarters and laying off a group of workers. Story

> Bind Therapeutics says its lead program for 014 demonstrated early signs of efficacy against solid tumors in a Phase I study. Release

> St. Jude says that European regulators have OK'd a new implant to treat dystonia. Report

Pharma News

 @FiercePharma: Trending yesterday: U.S. adults still skipping pills to save money, CDC finds. Article | Follow @FiercePharma

 @EricPFierce: Drugmakers with plants in EU still sweating whether China, India will meet deadline for new API regulations. Report | Follow @EricPFierce

> Lilly settles long-running lawsuit tying Cymbalta to teen's suicide. Story

> Merck kept mum on Fosamax's fracture risks, trial lawyer says. Report

Medical Device News

 @FierceMedDev: Report: Device tax is hard to decipher and kills jobs. More | Follow @FierceMedDev

 @MarkHFierce: Med device VC continues to be steady for late stage companies. iRhythm pulled in a $16M Series D. Release | Follow @MarkHFierce

 @DamianFierce: St. Jude won EU approval to treat dystonia with its deep-brain simulators. News | Follow @DamianFierce

> Abbott/BG heart failure Dx gains CE mark. More

> Smiths Medical faces FDA Class I recall over sleep alarm cables. Item

> Covidien plans to slash 183 jobs in NY plant closure. Report

Drug Delivery News

 @MichaelGFierce: From SpringLeaf's ashes, scPharma continues with minipump delivery. Article | Follow @MichaelGFierce

> TissueGen launches Elute drug-delivering fiber. News

> 3-D printer makes synthetic tissue for drug delivery. Report

> Self-assembling cancer drugs deliver themselves. Item

> Ambrx's cancer antibody delivery tech wins Astellas partnership. More

> Nano-delivered cell gatekeepers can improve drug performance, study finds. Story

And Finally… As Chinese officials revealed that 9 people have now died from a new strain of bird flu, raising alarms of a potential breakout, authorities also detained 10 people for supposedly spreading rumors about the spread of H7N9. Report

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.